IBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy effectiveness by 40% in patients with endometrial cancer

by AbilityPharma

The trial evaluated the safety and efficacy of ibrilatazar (ABTL0812) combined with paclitaxel/carboplatin in 51 patients with advanced or recurrent endometrial cancer, across 9 leading oncology hospi...

Read more

Exploring mechanisms of resistance against ER+ and BRCA1 breast cancer therapies

by Vall d’Hebron

Various research lines led by VHIO aim at better deciphering how tumor cells acquire resistance to anticancer agents including palbociclib and treatments inducing DNA damage. The expression of partial...

Read more

Official launch of Marie Sklodowska-Curie Innovative Training Network on PI3K signaling in health and disease coordinated by Dr Mariona Graupera

by IBEC - Institut de Bioenginyeria de Catalunya

A complete spectrum of scientific and technological capabilities is needed to decipher in detail how PI3K functions. To this end, European academic, clinical and industrial units in PI3K signalling ha...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream